Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TG Therapeutics

Request full access

TG Therapeutics - A Biopharmaceutical Company

Morrisville, United StatesFounded 2011Biotech & Life Sciences

About TG Therapeutics

TG Therapeutics is a commercial-stage biopharmaceutical company that acquires, develops, and commercializes treatments for B-cell malignancies and autoimmune diseases. The company's primary focus is on leveraging scientific advances in B-cell biology to develop novel treatments for patients. Its main product is BRIUMVI®, a treatment for relapsing forms of multiple sclerosis (RMS).

TG Therapeutics has a global license agreement with Precision BioSciences for the development and commercialization of Precision's allogeneic CD19 CAR T cell therapy program. The company's business model is focused on the acquisition, development, and commercialization of pharmaceutical products. TG Therapeutics generates revenue through the sale of its approved products.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2011
Headquarters
Morrisville, United States
Listing
IPO 2003
Sector
Biotech & Life Sciences
Outcome tier
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

TG Therapeutics in the Morrisville ecosystem

Live from Dealroom

The TG Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • Hercules Capital
  • Blue Owl Capital
  • HealthCare Royalty
  • ACT Capital Management
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States99.3%
🇧🇩 Bangladesh0.3%
🇮🇱 Israel0.3%
3 countries shown
Web traffic by country
66K monthly visits
across markets
🇺🇸 United States12.1%
🇨🇦 Canada2.4%
🇬🇧 United Kingdom2.1%
🇯🇵 Japan2%
🇮🇳 India1.8%
Top 5 markets shown

Patents

Estimated portfolio value
$391k

5 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TG Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TG Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.